Health Sciences In The Media

Bradley J. Monk, MD, FACS, FACOG, professor of obstetrics and gynecology in the College of Medicine – Phoenix, discusses the importance of helping patients make informed decisions about their care and the future role of antibody-drug conjugate targets in the biomarker testing arena.

A coalition of virologists convened at a two-day virtual conference, presented by the Global Virus Network, to ask and answer questions about what causes long COVID, how to predict who gets it, how to treat it and how to prevent it.

A large, prospective study found that women with endometriosis may have a higher risk of stroke compared with women without the chronic inflammatory condition.

An increasing number of people, including President Joe Biden, are getting infected with COVID-19 in spite of being vaccinated and boosted, but that doesn't mean the COVID-19 vaccine isn't working.

Patients with recurrent, platinum-resistant ovarian cancer have limited effective treatment options available, but a class of targeted antibody-drug conjugates represent a promising development for this population.

The International Agency for Research on Cancer recently classified occupational exposure as a firefighter as carcinogenic, changing the previous classification of possibly carcinogenic.

Obesity prevalence is on the rise across the U.S., but some groups are at a greater risk for the disease than others.

Wastewater research suggests there are far more new cases of COVID-19 than shown on the state data dashboard.

A team of University of Arizona Health Sciences and College of Engineering researchers created a simple, portable and inexpensive method for detecting extremely low levels of norovirus.

A phase 3 clinical trial studying the use of ofranergene obadenovec in combination with paclitaxel failed to meet its primary endpoint in improving progression-free survival or overall survival in patients with platinum-resistant ovarian cancer.